Myolex, Inc.
Publicly observedBrookline, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Brookline | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Myolex, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | XMRNG2MNK6F1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2025Publicly observed
NIH SBIR/STTR award: Electrical impedance myography (EIM) to detect and track cancer cachexia
USD 136,944.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Sept 2025Publicly observed
NIH SBIR/STTR award: Electrical impedance myography (EIM) to detect and track cancer cachexia
USD 263,052.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant15 Jun 2024Publicly observed
NIH SBIR/STTR award: Convenient quantification of myopathic change in muscle via electrical impedance myography
USD 963,608.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.